These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6850903)

  • 1. [Comparison of the clinical reactivity and immunological effectiveness of adsorbed and non-adsorbed sub-unit influenza vaccine].
    Domorázková E; Závadová H; Bergmannová V; Vodicková M; Fitzek J; Ragac P; Vonka V
    Cesk Pediatr; 1983 Mar; 38(3):146-8. PubMed ID: 6850903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the immunologic effectiveness of SUBINVIRA type B (sub-unit influenza virus vaccine) in children after administration of various doses].
    Závadová H; Domorázková E; Ragac P; Vonka V
    Cesk Pediatr; 1984 Jan; 39(1):21-3. PubMed ID: 6705099
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influenza vaccination of children with a sub-unit vaccine made in Czechoslovakia].
    Domorázková E; Závadová H; Bergmannová V; Stehlíková J; Vodicková M; Vonka V
    Cesk Pediatr; 1981 Feb; 36(2):100-2. PubMed ID: 7471291
    [No Abstract]   [Full Text] [Related]  

  • 4. Subunit influenza vaccine and its testing in clinical immunology.
    Zykov MP; Rudenko LG; Zoshchenkova NY; Rafael'skaya TI
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):212-8. PubMed ID: 6997374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E; Thraenhart O; Werner J; Höher PG
    Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the antigenic activity of an adsorbed influenza chemical (AIC) vaccine by an antibody sorption method].
    Starukhina GN; Isupov FG; Egorov PA
    Tr Inst Im Pastera; 1976; 47():60-6. PubMed ID: 802569
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 10. [The prospects for using inactivated influenza vaccines on the troops].
    Furgal SM; Degtiarev AA; Korol'kov VF
    Voen Med Zh; 1993 May; (5):35-6, 80. PubMed ID: 8356819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactogenicity and immunogenic activity of live influenza vaccines made from recombinant viruses].
    Vasil'eva RI; Koliakh LI; Rumel' NB; Erofeeva MK; Maksakova VL
    Tr Inst Im Pastera; 1982; 58():19-22. PubMed ID: 6764980
    [No Abstract]   [Full Text] [Related]  

  • 12. Avian influenza. 'Pandemic vaccine' appears to protect only at high doses.
    Enserink M
    Science; 2005 Aug; 309(5737):996. PubMed ID: 16099954
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.
    Hurwitz ES; Haber M; Chang A; Shope T; Teo ST; Giesick JS; Ginsberg MM; Cox NJ
    J Infect Dis; 2000 Oct; 182(4):1218-21. PubMed ID: 10979921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influenza epidemic in a nursing home caused by a virus not included in the vaccine].
    Beyer WE; Bakker G; van Beek R; Masurel N
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1973-7. PubMed ID: 8413706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 18. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

  • 19. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
    Del Giudice G; Hilbert AK; Bugarini R; Minutello A; Popova O; Toneatto D; Schoendorf I; Borkowski A; Rappuoli R; Podda A
    Vaccine; 2006 Apr; 24(16):3063-5. PubMed ID: 16464520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.